A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lemborexant in Subjects with Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
Clinical Trial Grant
Administered By
Neurology, Behavioral Neurology
Awarded By
Eisai, Inc.
Start Date
December 7, 2017
End Date
November 13, 2018
Administered By
Neurology, Behavioral Neurology
Awarded By
Eisai, Inc.
Start Date
December 7, 2017
End Date
November 13, 2018